XTX Topco Ltd bought a new stake in shares of Celanese Co. (NYSE:CE – Free Report) in the 3rd quarter, Holdings Channel reports. The institutional investor bought 6,276 shares of the basic materials company’s stock, valued at approximately $853,000.
Several other institutional investors also recently bought and sold shares of the stock. DT Investment Partners LLC grew its stake in shares of Celanese by 128.8% in the 3rd quarter. DT Investment Partners LLC now owns 183 shares of the basic materials company’s stock worth $25,000 after buying an additional 103 shares in the last quarter. Fairscale Capital LLC purchased a new position in shares of Celanese in the 2nd quarter worth $28,000. Key Financial Inc grew its stake in shares of Celanese by 3,933.3% in the 2nd quarter. Key Financial Inc now owns 242 shares of the basic materials company’s stock worth $33,000 after buying an additional 236 shares in the last quarter. ORG Partners LLC purchased a new position in shares of Celanese in the 2nd quarter worth $40,000. Finally, Rothschild Investment LLC purchased a new position in shares of Celanese in the 2nd quarter worth $40,000. 98.87% of the stock is owned by hedge funds and other institutional investors.
Celanese Trading Down 3.8 %
NYSE:CE opened at $69.64 on Wednesday. The company has a debt-to-equity ratio of 1.47, a quick ratio of 0.76 and a current ratio of 1.37. The firm has a market cap of $7.61 billion, a P/E ratio of 7.01, a P/E/G ratio of 0.75 and a beta of 1.18. The firm has a 50-day simple moving average of $102.61 and a 200-day simple moving average of $123.44. Celanese Co. has a one year low of $68.88 and a one year high of $172.16.
Celanese Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, November 13th. Shareholders of record on Wednesday, October 30th were paid a dividend of $0.70 per share. The ex-dividend date was Wednesday, October 30th. This represents a $2.80 dividend on an annualized basis and a yield of 4.02%. Celanese’s payout ratio is 28.17%.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on CE shares. Piper Sandler cut shares of Celanese from a “neutral” rating to an “underweight” rating and dropped their price objective for the stock from $150.00 to $98.00 in a research note on Friday, November 8th. UBS Group lowered shares of Celanese from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $161.00 to $97.00 in a report on Monday, November 11th. Barclays lowered their target price on shares of Celanese from $101.00 to $88.00 and set an “equal weight” rating for the company in a report on Tuesday, November 19th. Mizuho lowered their target price on shares of Celanese from $120.00 to $86.00 and set a “neutral” rating for the company in a report on Thursday, December 5th. Finally, BMO Capital Markets lowered shares of Celanese from a “market perform” rating to an “underperform” rating and lowered their target price for the stock from $138.00 to $76.00 in a report on Monday, November 11th. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $116.56.
View Our Latest Analysis on CE
Celanese Company Profile
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
See Also
- Five stocks we like better than Celanese
- What is Forex and How Does it Work?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Upcoming IPO Stock Lockup Period, Explained
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- The Role Economic Reports Play in a Successful Investment Strategy
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Want to see what other hedge funds are holding CE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celanese Co. (NYSE:CE – Free Report).
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.